Abstract 4177: An IL13Rα2 peptide inhibits colorectal cancer metastatic progression
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Research"
DOI: 10.1158/1538-7445.am2018-4177
Abstract: Interleukin 13 receptor α2 (IL13Rα2) is an excellent tumoral marker for metastatic colorectal cancer and glioblastoma. Our goal was to block IL-13 binding to IL13Rα2 by using IL13Rα2 synthetic peptides in order to delay or… read more here.
Keywords: cancer; il13r peptide; metastatic progression; colorectal cancer ... See more keywords